VA | Non-VA | Unadjusted difference | Adjusted difference* | |
Medication discrepancies† (mean (SD)) | 2.62 (2.16) | 2.55 (2.18) | Diff 0.07 (−0.26 to 0.42) | Diff 0.02 (−0.81 to 0.85) |
High-risk medication discrepancies† (mean (SD)) | 0.96 (1.07) | 0.75 (0.92) | Diff 0.21 (0.05 to 0.38)§ | Diff −0.18 (−0.22 to 0.58) |
ADE caused by a medication discrepancy‡ (% of hospitalisation episodes) | 18.1% | 21.5% | OR 0.83 (0.44 to 1.59) | OR 0.96 (0.18 to 5.01) |
(Subsample n=127 VA; n=177 non-VA) |
↵* All models were adjusted for gender, age, prehospitalisation number of medications, Charlson comorbidity score, APACHE score, off-hours admission, admission diagnoses and duration of follow-up.
↵† At the time of hospital admission.
↵‡ At the time of hospital admission or discharge.
↵§ p=0.01 for VA/non-VA group comparison.
ADE, adverse drug events; VA, US Department of Veterans Affairs.